Dehydroepiandrosterone sulfate (DHEA-S) and Alzheimer's dementia in older subjects

International Journal of Geriatric Psychiatry

Volumn 21, Issue 11, 2006, Pages 1065-1070

  Bo, Mario ^a   Massaia, Massimiliano ^a   Zannella, Patrizia ^a   Cappa, Giorgetta ^a   Ferrario, Ermanno ^a   Rainero, Innocenzo ^a   Arvat, Emanuela ^b   Giordano, Roberta ^b   Molaschi, Mario ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Alzheimer's dementia; Dehydroepiandrosterone sulphate; Elderly

Indexed keywords

PRASTERONE SULFATE;

AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION DISTURBANCE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ELDERLY CARE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MORTALITY; NEUROPSYCHOLOGICAL TEST; PROPORTIONAL HAZARDS MODEL; WORKING MEMORY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; MALE; SURVIVAL RATE;

EID: 33751093749     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1608     Document Type: Article

References (39)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders (4th edn). American Psychiatric Association: Washington, DC.
2. Barret-Connor E, Edelstein S. 1994. A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: the Rancho Bernardo Study. J Am Geriatr Soc 42: 420-423.
3. Barret-Connor E, Khaw K. 1987. Absence of an inverse relation of dehydroepiandrosterone sulfate with cardiovascular mortality in postmenopausal women. N Engl J Med 317: 711-716.
4. Barret-Connor E, Khaw K, Yen SSC. 1986. A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. N Engl J Med 315: 1519-1524.
5. Barret-Connor E, Kritz-Silvestein D, Edelstein SL. 1993. A prospective study of dehydroepiandrosterone sulfate (DHEA-S) and bone mineral density in older men and women. Am J Epidemiol 137: 201-206.
6. Baulieu EE. 1996. Dehydroepiandrosterone sulfate (DHEA-S): a fountain of youth? J Clin Endocrinol Metab 81: 3147-3151.
7. Berr C, Lafont S, Debuire B, et al. 1996. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a french community-based study. Proc Natl Acad Sci USA 93: 13410-13415.
8. Ceresini G, Freddi M, Mazza S, et al. 1997. Concomitant evaluation of dehydroepiandrosterone sulfate and gonadal steroids in both serum and cerebrospinal fluid from human male subjects. In 79th Annual Meeting of Endocrine Society, Abstract Book. Masson Italia Periodici srl: Milano; 217.
9. Cuckle H, Stone R, Smith D, et al. 1990. Dehydroepiandrosterone sulfate in Alzheimer's disease. Lancet ii: 449-450.
10. De Renzi E, Vignolo LA. 1962. The Token Test: a sensitive test to detect receptive disturbances in aphasics. Brain 85: 665-678.
11. Flood JF, Roberts E. 1988. Dehydroepiandrosterone improves memory in aging mice. Brain Res 448: 178-181.
12. Flood JF, Smith GE, Roberts E. 1988. Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res 447: 269-278.
13. Herrington DM, Gordon GB, Achuff SC. 1990. Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients it undergoing diagnostic coronary angiography. J Am Coll Cardiol 16: 862-870.
14. Hillen T, Lun A, Reischies FM, et al. 2000. DHEA-S plasma levels and incidence of Alzheimer's disease. Biol Psychiatry 47: 161-163.
15. Horani MH, Morley JE. 2004. Hormonal fountains of youth. Clin Geriatr Med 20: 275.
16. Kimonides VG, Khatibi NH, Svedsen CN, et al. 1998. Dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEA-S) protect hippocampal neurons against excitatory aminoacid induced neurotoxicity. Proc Natl Acad Sci USA 85: 1852-1857.
17. Leblhuber F, Neubauer C, Peichl M, et al. 1993. Age and sex differences of dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels in normal controls and Alzheimer's disease (AD). Psychopharmacology (Berl) 111(1): 23-26.
18. Legrain S, Berr C, Frenoy N, et al. Dehydroepiandrosterone sulfate in a long term care aged population 1995. Gerontology 41: 343-351.
19. McKahnn G, Drachman D, Folstein M. 1984. Clinical diagnosis of Alzheimer's disease: reports of the NINCDS-ARDRA Work Group under auspices of department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944.
20. Morales AJ, Nolan JJ, Nelson JC, et al. 1994. Effects of replacement doses of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78: 1360-1367.
21. Nippoldt TB. 1998. Dehydroepiandrosterone supplements: bringing sense to sensational claims. Endocr Pract 4(2): 106-111.
22. Nordin BEC, Robertson A, Seamark RF. 1985. The relation between calcium absorption, serum dehydroepiandrosterone and vertebral mineral density in postmenopausal women. J Clin Endocrinol Metab 60: 651-657.
23. Orentreich N, Brind JL, Rizer L, et al. 1984. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59: 551-555.
24. Orentreich N, Brind JL, Vogelman JH, et al. 1992. Long term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 75: 1002-1004.
25. Practice parameter for diagnosis and evaluation of dementia. (Summary statement) 1994. Neurology 44: 2203-2206.
26. Randt CT, Brown ER. 1983. Randt Memory Test. Life Science Associates: Bayport, NY.
27. Rhodes ME, Li PK, Burke AM, et al. 1997. Enhanced DHEA-S, brain acetylcholine and memory mediated by steroid sulfatase inhibition. Brain Res 773: 28-32.
28. Roberts E, Bologa L, Flood JF, et al. 1987. Effects of dehydroepiandrosterone and its sulfate on brain tissue and on memory in mice. Brain Res 406: 357-362.
29. Roman GC, Tatemichi TK, Erkinhutti T, et al. 1993. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43: 250-260.
30. Salvini S, Stampfer MJ, Barbieri RL, et al. 1992. Effects of age, smoking, and vitamins on plasma DHEA-S levels: a cross-sectional study in men. J Clin Endocrinol Metab 74: 139-143.
31. Schneider LS, Hinsey M, Lyness S. 1992. Plasma dehydroepiandrosterone sulfate in Alzheimer's disease. Biol Psychiatry 31: 205-208.
32. Spath-Schwalbe E, Dodt C, Dittmann J, et al. 1990. Dehydroepiandrosterone sulphate in Alzheimer disease. Lancet 335(8702): 1412.
33. Spinnler H, Tognoni G. 1987a. Standardizzazione e taratura italiana di test neuropsicologici. Masson Italia Periodici srl: Milano, suppl. 8.
34. Spinnler H, Tognoni G. 1987b. Standardizzazione e taratura italiana di test neuropsicologici. Italian J Neurologic Sci Suppl 6(Dec): 5-120.
35. Sunderland T, Merril CR, Harrington MG, et al. 1989. Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. Lancet 2(8662): 570.
36. Tenover JL. 1998. Trophic factors and male hormone replacement. In Principles of Geriatric Medicine & Gerontology, (5th edn). Hazzard WR, Blass JP, Halter JB, et al. (eds). McGraw Hill: New York; 1325.
37. Wolf OT, Kirschbaum C. 1999. Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res Rev 30: 264-288.
38. Wolkowitz OM, Kramer JM, Reus VI, et al. 2003. DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled trial. Neurology 6: 1071-1076.
39. Yaffe K, Ettinger B, Pressman A, et al. 1998. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biol Psyxhiatry 43: 694-700.